Key facts
- Notable investors include Plum Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Mystbio
- ·The full record, as it builds
Funding rounds
No funding rounds for Mystbio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mystbio
Developer of data-driven biotechnology platform designed to advance innovative molecular diagnostics and intelligent diagnostic technologies for oncology. The company offers cross-disciplinary expertise, advanced medical data platforms, intelligent algorithm-based diagnostic tools, and personalized analytical capabilities, enabling healthcare institutions and oncology practitioners to improve clinical decision-making and enhance precision treatment outcomes.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2024
- Website
- myst-bio.com/
- Ownership
- Privately Held (backing)
Mystbio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mystbio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mystbio in its N-PORT filings yet. We sweep new filings monthly.